Антираковая диета. Продукты, которые мы должны есть, чтобы защититься от опасного недуга - Хаят Давид (книги онлайн полностью .txt) 📗

{50} MacMahon B., Yen S., Trichopoulos D., Warren K., Nardi G. «Coffee and cancer of the pancreas», N. Engl. J. Med., 1981, 304 (11), p. 630–633.

{51} Nkondjock A., «Coffee consumption and the risk of cancer: An overview», Cancer Lett., 2008, 277 (2), p. 121–125.

{52} World Cancer Research Fund, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, op. cit.

{53} Pelucchi C., Tavani A., La Vecchia C., «Coffee and alcohol consumption and bladder cancer», Scand. J. Urol. Nephrol., 2008, 218, suppl., p. 37–44.

{54} Baker J. A., Beehler G. P., Sawant A. C., Jayaprakash V., Mc-Cann S. E., Moysich K. B., «Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer», J. Nutr., 2006, 136 (1), p. 166–171.

{55} Nkondjock A., Ghadirian P., Kotsopoulos J., Lubinski J., Lynch H., Kim Sing C., Horsman D., Rosen B., Isaacs C., Weber B., Foulkes W., Ainsworth P., Tung N., Eisen A., Friedman E., Eng C., Sun P., Narod S. A., «Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers», Int. J. Cancer, 2006, 118 (1), p. 103–107.

{56} Shanafelt T. D., Lee Y. K., Call T. G., Nowakowski G. S., Dingli D., Zent C. S., Kay N. E., «Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies», Leuk. Res., 2006, 30 (6), p. 707–712.

{57} Tsao A. S., Liu D., Martin J., Tang X. M., Lee J. J., El-Naggar A. K., Wistuba I., Culotta K. S., Mao L., Gillenwater A., Sagesaka Y. M., Hong W. K., Papadimitrakopoulou V., «Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions», Cancer Prev. Res. (Phila Pa), 2009, 2 (11), p. 931–941.

{58} Tsao A. S., Liu D., Martin J., Tang X. M., Lee J. J., El-Naggar A. K., Wistuba I., Culotta K. S., Mao L., Gillenwater A., Sagesaka Y. M., Hong W. K., Papadimitrakopoulou V., «Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions», op. cit.

{59} World Cancer Research Fund, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, op. cit.

{1} Vidal, Le Guide Vidal des complements alimentaires disponible en librairie, Communique de Presse, 2010. Disponible sur: http://www. vidal.fr/presse/espace-grand-public/363-guide-complements-alimentaires (consulte le 15 mars 2010).

{2} AFSSA, Etude individuelle nationale des consommations alimentaires 2 (INCA 2) 2006–2007, 2009. Disponible sur: http://www.afssa.fr/ Documents/PASER-Ra-INCA2.pdf (consulte le 15 mars 2010).

{3} Ferrucci L. M., McCorkle R., Smith T., Stein K. D., Cartmel B., «Factors related to the use of dietary supplements by cancer survivors», J. Altern. Complement. Med., 2009, 15 (6), p. 673–680.

{4} Cassileth B. R., Heitzer M., Wesa K., «The public health impact of herbs and nutritional supplements», Pharm. Biol., 2009, 47 (8), p. 761–767.

{5} Kimura Y., Ito H., Ohnishi R., Hatano T., «Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity», Food Chem. Toxicol., 2009, 48 (1), p. 429–435.

{6} Goodman G. E., Thornquist M. D., Balmes J., Cullen M. R., Meyskens F. L. Jr, Omenn G. S., Valanis B., Williams J. H. Jr., «The beta-carotene and retinol efficacy trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements», J. Natl. Cancer Inst., 2004, 96 (23), p. 1743–1750.

{7} Virtamo J., Pietinen P., Huttunen J. K., Korhonen P., Malila N., Virtanen M. J., Albanes D., Taylor P. R., Albert P., ATBC Study Group, «Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: A postintervention follow-up», JAMA, 2003, 290 (4), p. 476–485.

{8} Cook N. R., Le I. M., Manson J. E., Buring J. E., Hennekens C. H., «Effects of beta-carotene supplementation on cancer Incidence by baseline characteristics in the Physicians’ Health Study (United States)», Cancer Causes Control, 2000, 11 (7), p. 617–626.

{9} Lee I. M., Cook N. R., Manson J. E., Buring J. E., Hennekens C. H., «Beta-carotene supplementation and Incidence of cancer and cardiovascular disease: The Women’s Health Study», J. Natl. Cancer Inst., 1999, 91 (24), p. 2102–2106.

{10} De Klerk N. H., Musk A. W., Ambrosini G. L., Eccles J. L., Hansen J., Olsen N., Watts V. L., Lund H. G., Pang S. C., Beilby J., Hobbs M. S., «Western perth asbestos workers, Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene», Int. J. Cancer, 1998, 75 (3), p. 362–367.

{11} Hercberg S., Kesse-Guyot E., Druesne-Pecollo N., Touvier M., Favier A., Latino-Martel P., Briancon S., Galan P., «Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: A postintervention follow-up in the SU.VI.MAX Study», Int. J. Cancer, 2010, epub.

{12} Meyer F., Galan P., Douville P., Bairati I., Kegle P., Bertrais S., Estaquio C., Hercberg S., «Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial», Int. J. Cancer, 2005, 116 (2), p. 182–186.

{13} Hercberg S., Ezzedine K., Guinot C. et al., «Antioxidant supplementation increases the risk of skin cancers in women but not in men», J. Nutr., 2007, 137, p. 2098–2105.

{14} Omenn G. S., Goodman G. E., Thornquist M. D., Balmes J., Cullen M. R., Glass A., Keogh J. P., Meyskens F. L. Jr, Valanis B., Williams J. H. Jr, Barnhart S., Cherniack M. G., Brodkin C. A., Hammar S., «Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene and retinol efficacy trial», J. Natl. Cancer Inst, 1996, 88 (21), p. 1550–1559.

{15} National Cancer Institute, Selenium and Vitamin E Cancer Prevention Trial (SELECT), 2008. Disponible sur: http://www.cancer.gov/ newscenter/pressreleases/SELECTQandA (consulte le 15 mars 2010).

{16} Nelson R. L., «Iron and colorectal cancer risk, human studies», Nutr. Rev., 2001, 59, p. 140–148.

{17} Duffield-Lillico A. J., Dalkin B. L., Reid M. E., Turnbull B. W., Slate E. H., Jacobs E. T., Marshall J. R., Clark L. C., «Nutritional Prevention of Cancer Study Group. Selenium supplementation, baseline plasma selenium status and Incidence of prostate cancer: An analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial», BJU Int. 2003, 91 (7), p. 608—6012.

{18} Clark L. C., Combs G. F. Jr, Turnbull B. W., Slate E. H., Chalker D. K., ChowJ., Davis L. S., Glover R. A., Graham G. F., Gross E. G., KrongradA., Lesher J. L. Jr, Park H. K., Sanders B. B. Jr, Smith C. L., Taylor J. R., «Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial», JAMA, 1996, 276 (24), p. 1957–1963.

{19} Ibid.

{20} World Cancer Resarch Fund, Food, Nutrition, Physical Activity and the Prevention of Cancer. A Global Perspective, op. cit.

{21} Ibid.

{22} Jenab M., Bueno-de-Mesquita H. B., Ferrari P., Van Duijnhoven F. J., Norat T., Pischon T., Jansen E. H., Slimani N., Byrnes G., Rinaldi S., Tjonneland A., Olsen A., Overvad K., Boutron-Ruault M. C., Clavel-Chapelon F., Morois S., Kaaks R., LinseisenJ., Boeing H., Bergmann M. M., Tichopoulou A., Misirli G., Trichopoulos D., Berrino F., Vineis P., Panico S., Palli D., Tumino R., Ros M. M., Van Gils C. H., Peeters P. H., Brustad M., Lund E., Tormo M. J., Ardanaz E., Rodriguez L., Sanchez M. J., Dorronsoro M., Gonzalez C. A., Hallmans G., Palmqvist R., Roddam A., Key T. J., Khaw K. T., Autier P., Hainaut P., Riboli E., «Association between prediagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: A nested case-control study», BMJ, 2010, 340, p. b5500.